Prof. Dr. med. Oliver Schnell

Lehrstuhl für Neurochirurgie

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial (2016) Herrlinger U, Schaefer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Friedrich F, et al. Journal article Endotracheal tube electrodes to assess vocal cord motor function during surgery in the cerebellopontine angle (2015) Romagna A, Rachinger W, Schwartz C, Mehrkens JH, Betz C, Briegel J, Schnell O, et al. Journal article Surgical resection: Techniques, intra-operative update, and outcome (2015) Schnell O, Tonn JC Authored book MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive Glioblastoma: The DIRECTOR Trial (2015) Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, et al. Journal article A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma (2015) Westphal M, Heese O, Steinbach JP, Schnell O, Schackert G, Mehdorn M, Schulz D, et al. Journal article Hippocampal EUD in primarily irradiated glioblastoma patients (2014) Bodensohn R, Söhn M, Ganswindt U, Schupp G, Nachbichler SB, Schnell O, Belka C, Niyazi M Journal article Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (2014) Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, et al. Journal article Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients (2014) Jansen NL, Suchorska B, Wenter V, Eigenbrod S, Schmid-Tannwald C, Zwergal A, Niyazi M, et al. Journal article 5-ALA based photodynamic management of glioblastoma (2014) Rühm A, Stepp H, Beyer W, Hennig G, Pongratz T, Sroka R, Schnell O, et al. Conference contribution A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network (2013) Seidel C, Hentschel B, Simon M, Schnell O, Heese O, Tatagiba M, Krex D, et al. Journal article